Also, the IC50 value of some chemotherapeutic agents was lower in the H‐risk group, containing AZD1332‐1463, IGF1R‐3801‐1738, and XAV939‐1268, indicating that AZD1332‐1463, IGF1R‐3801‐1738, and XAV939‐1268 were potentially beneficial for CRC patients in the H‐risk group. The gene discussed is IGF1R; the disease is colorectal carcinoma.